About RS2 Healthcare Partners
RS2 Healthcare Partners (formerly Riverside Partners) is a Boston-based lower middle market private equity firm that exclusively focuses on healthcare investing across high-growth subsectors including pharma services, medical device contract manufacturing, healthcare IT, medical products and equipment, provider and payer services, lab products and services, providers and practice management, and technology-enabled healthcare. The firm targets companies with EBITDA of $3 million to $15 million and pursues control-oriented buyouts, management buyouts, management buyins, growth equity investments, and strategic add-on acquisitions alongside its platform portfolio companies. RS2 Healthcare Partners seeks both majority control positions with management rollover and minority growth equity stakes depending on transaction structure and company stage. The firm invests across North America, with international acquisition programs executed through portfolio companies. RS2 Healthcare Partners operates with the support of dedicated Healthcare, Clinical, and AI Advisory Boards comprising more than 30 executives, clinicians, and technology experts from leading healthcare organizations, partnering closely with founders and management teams to provide strategic guidance, operational support, and access to a deep industry network throughout the investment lifecycle. Founded in 1989 as Riverside Partners and rebranded as RS2 Healthcare Partners in May 2026, the firm is headquartered in Boston, Massachusetts, United States.